You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Akt Inhibitors to Treat Ewing's Sarcoma

    SBC: Acenta Discovery, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Novel drugs that improve overall survival with decreased morbidity are critical in the war on cancer. Acenta Discovery Inc. has partnered with the Toretsky Lab of the Lombardi Cancer Center to create and preclinically evaluate novel inhibitors of the protein Akt. An Akt inhibitor would have tremendous value in improving the lives of patients with many types ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  2. Caspase Inhibitor for Neuroprotection

    SBC: Acenta Discovery, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): An important role for apoptosis has been established in various pathological processes, particularly in nervous tissues. Apoptosis essentially contributes to neuronal loss during normal development, after acute neuronal injury, and in chronic degenerative conditions such as Alzheimer's disease, Huntington's disease, Parkinson's disease, and amyotrophic lateral ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  3. Define/Demonstrate Non-hazardous or Less Hazardous Beryllium (Be) Material for Defense Applications

    SBC: Sensintel Inc.            Topic: MDA04059

    Advanced Ceramics Research (ACR) will identify, evaluate and select the most promising technologies for a high stiffness, stable and healthy ceramic or ceramic composite material for the replacement of beryllia and beryllium in structural application such as mirror substrates, electrical and electronic substrate materials. As a part of the identification and selection of the most promising techno ...

    SBIR Phase I 2004 Department of DefenseMissile Defense Agency
  4. High-Strength Carbide-Based Fibrous Monolith Materials for Solid Rocket Nozzles

    SBC: Sensintel Inc.            Topic: MDA04T024

    On this Phase I STTR program, Advanced Ceramics Research Inc. (ACR) will team with the University of Missouri ¡V Rolla (UMR) to develop high strength, thermal shock resistant tantalum carbide (TaC) or hafnium carbide (HfC)-based Fibrous Monolith composite materials for use in ultra-high temperature (>6000,aF) solid rocket motor environments. These materials will exhibit the high toughness of fib ...

    STTR Phase I 2004 Department of DefenseMissile Defense Agency
  5. Small low-cost energetic components for the Miniature Kill Vehicle (MKV)

    SBC: Sensintel Inc.            Topic: MDA04009

    In this phase I SBIR program, Advanced Ceramics Research, Inc. (ACR) proposes the development of an innovative manufacturing technique for combination of energetic materials that can be manufactured into lightweight, fine-featured structural components for the DACS systems to enhance the lethality of a miniature kill vehicle. The proposed technique will leverage ACR's experience with gel-casting s ...

    SBIR Phase I 2004 Department of DefenseMissile Defense Agency
  6. Implantable Noise-based Sensory Enhancement Devices

    SBC: AFFERENT CORPORATION            Topic: N/A

    DESCRIPTION (provided by applicant): Stroke survivors constitute one of the largest groups of patients receiving rehabilitation services in the United States. The inability of most stroke survivors to regain full sensorimotor function significantly impacts quality of life while generating tremendous ongoing health care costs and losses to productivity. Recent scientific and clinical findings have ...

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  7. TRACHEAL GAS INSUFFLATION- PATIENT INTERFACE SYSTEM

    SBC: ALVEOLI MEDICAL, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The benefits of Tracheal Gas Insufflation (TGI) as an adjunct to mechanical ventilation are well known. 1 TGI reduces dead space and CO2 rebreathing in mechanically ventilated patients, thereby reducing PaCO2 with no c

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  8. Low-temperature Electrocatalytic Oxidation of VOCs

    SBC: AMSEN TECHNOLOGIES LLC            Topic: N/A

    DESCRIPTION (provided by applicant): In this program AMSEN Technologies aims to develop a novel electrocatalytic air filter for low-temperature oxidative destruction of VOCs. The proposed idea is an innovative combination of electrochemically enhanced ads

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  9. Transgenic indicator cells for influenza virus

    SBC: APATH, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Influenza virus causes a pandemic disease of the respiratory tract that results in significant human morbidity and mortality. Diagnosis of influenza virus infection during the winter months makes up a large component

    SBIR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  10. Molecular tools for Bunyavirus antiviral screening

    SBC: APATH, LLC            Topic: N/A

    DESCRIPTION (provided by investigator): Several viruses in the family Bunyaviridae are significant human pathogens and potential agents of bioterrorism. Vaccines against some of these viruses do exist, but with the exception of ribavarin, there are no broad-spectrum antiviral compounds capable of inhibiting replication of more than one member of the family. Using LaCrosse virus (LAC) as a prototyp ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government